Journal: Journal of Advanced Research
Article Title: Mitochondrial fatty acid oxidation as the target for blocking therapy-resistance and inhibiting tumor recurrence: The proof-of-principle model demonstrated for ovarian cancer cells
doi: 10.1016/j.jare.2025.03.026
Figure Lengend Snippet: Paclitaxel induced transient ovarian cancer persister cells. ( A ) Schematic representation of paclitaxel-tolerant persister cell generation. ( B ) Representative morphological images of parental, persister, regrown and resistant cells captured under a phase contrast microscope. Scale bar, 100 μm. ( C ) OVCAR8 and A2780 cells were treated with 20 nM paclitaxel for 9 days and then withdrawn. The cell viability was evaluated daily using Alamar Blue assay for 40 days and normalized to that on day 1. ( D ) Cell proliferation was measured by CFSE dilution assay. CFSE divides between daughter cells upon cell division and can be tracked by decreasing the fluorescence intensity. ( E ) Parental, persister, and regrown cells derived from OVCAR8 (left) and A2780 (right) cell lines were treated with various concentrations of paclitaxel ranging from 1 to 1 × 10 4 nM for 48 h, and cell viability was assessed using CCK-8 assay. ( F ) Heatmap representing the IC 50 values of paclitaxel at 48 h in parental, persister and regrown cells derived from OVCAR8 (left) and A2780 (right) cell lines. ( G ) Quantification of annexin V-positive apoptotic parental, persister, and regrown cells derived from OVCAR8 (left) and A2780 (right) cell lines after vehicle or paclitaxel treatment. CFSE, carboxyfluorescein diacetate succinimidyl ester. PTX, paclitaxel. IC 50 , half maximal inhibitory concentration. ns, not statistically significant; ** P < 0.01; *** P < 0.001. The values are presented as the means ± SDs.
Article Snippet: Cell proliferation was measured using Alamar Blue (Yeasen, China) assay, carboxyfluorescein diacetate succinimidyl ester (CFSE, MedChemExpress, USA) dilution assay or cell counting kit-8 (CCK-8, Beyotime, China) assay; and cytotoxicity was evaluated by CCK-8 assay or CellTiter-Glo® 2.0 cell viability assay (Promega, USA) according to the manufacturer’s protocol (see “Cell proliferation and cytotoxicity” in the Supplementary Material for additional details).
Techniques: Microscopy, Alamar Blue Assay, Dilution Assay, Fluorescence, Derivative Assay, CCK-8 Assay, Concentration Assay